Apellis Pharmaceuticals Stock Forward View - Day Typical Price
| APLS Stock | USD 17.21 -0.76 -4.23% |
The Day Typical Price reference data for Apellis Pharmaceuticals is derived from the equity's published trading history. Forecast values and accuracy indicators are summarized on this page for reference.
The period considered in calculating typical price is a single trading day, however the typical price can also be applied to other time spans such as a week, month or year. All forecast values on this page for Apellis Pharmaceuticals are Day Typical Price reference data derived from historical price series. Day Typical Price Analysis Today
Apellis Pharmaceuticals has current Day Typical Price of 17.49. Typical Price is calculated as arithmetic average of the high, low and closing price for a given trading period.| Previous Day Typical Price | Day Typical Price | Trend |
| 17.85 | 17.49 |
| Volatility | Backtest | Information Ratio |
Apellis Pharmaceuticals Trading Date Momentum
| On March 20 2026 Apellis Pharmaceuticals was traded for 17.21 at the closing time. The top price for the day was 18.09 and the lowest listed price was 17.16 . The trading volume for the day was 4.8 M. The trading history from March 20, 2026 did not affect price variability. The overall trading delta against the current closing price is 4.36% . |
The period considered in calculating typical price is a single trading day, however the typical price can also be applied to other time spans such as a week, month or year.
| Compare Apellis Pharmaceuticals to competition |
Other Forecasting Options for Apellis Pharmaceuticals
For both new and experienced investors in Apellis, the ability to analyze Apellis Pharmaceuticals' price movement is a fundamental investment skill. Price chart noise in Apellis Stock can create false signals and mislead investment decisions.Apellis Pharmaceuticals Related Equities
The following equities are related to Apellis Pharmaceuticals within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Apellis Pharmaceuticals against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Apellis Pharmaceuticals Market Strength Events
Tracking market strength indicators for Apellis Pharmaceuticals provides context for understanding the momentum dynamics of the stock in real time. These signals support informed decisions about when to enter or exit positions in Apellis Pharmaceuticals for maximum return potential.
Apellis Pharmaceuticals Risk Indicators
Properly assessing Apellis Pharmaceuticals' risk indicators is a prerequisite for building reliable price forecasts. Identifying and quantifying the risks associated with Apellis Pharmaceuticals' allows investors to make better-informed decisions about accepting or hedging their exposure.
| Mean Deviation | 2.33 | |||
| Standard Deviation | 3.43 | |||
| Variance | 11.76 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Apellis Pharmaceuticals
The amount of media and story coverage tied to Apellis Pharmaceuticals can signal where market attention is concentrating at the moment. Used properly, this context can help investors judge whether visibility is reinforcing the thesis or attracting more speculative pressure.
Contributor Headline
Latest Perspective From Macroaxis
Apellis Pharmaceuticals Short Properties
Reviewing short-oriented indicators for Apellis Pharmaceuticals is useful because long and short participants often create very different signals for timing and volatility. The stronger read compares short sentiment with trend behavior, volume, and the broader market narrative.
| Common Stock Shares Outstanding | 126 M | |
| Cash And Short Term Investments | 467.8 M |
Additional Tools for Apellis Stock Analysis
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Holdings Check your current holdings and cash position to determine if your portfolio needs rebalancing | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |